The Implementation of Antimicrobial Stewardship Using a Multidisciplinary Approach

Program Overview

Release Date: March 1, 2008        Expiration Date: February 28, 2009

Accreditation For Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity provides 1.0 hour (0.1 CEU) of continuing education credit (program number 204-000-07-467-H01P). 

Methods/Format

This is an online activity consisting of audio, presentation slides, post-test, and activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time required to complete this activity is one hour. This activity is provided free of charge.

Target Audience

This continuing education activity was planned to meet the needs of health-system pharmacy practitioners in academic, administrative, clinical, managed care, and supportive roles.

Activity Content

Click here to view an overview of the activity content.

Learning Objectives

After participating in this educational activity, participants should be able to:

• Explain the relationship between dyslipidemia, the metabolic syndrome, and CHD, and discuss the prevalence of and morbidity and mortality from these conditions.
• Summarize the current NCEP guidelines for treating dyslipidemia, and identify a persistent myth or an unresolved controversy in dyslipidemia treatment that is not adequately addressed by the guidelines.
• Explain the importance of HDL cholesterol in determining CHD risk and the impact of raising levels on CHD risk.
• Describe the role of statins, niacin, fibrates, and other agents in the treatment of dyslipidemia, including effects of the drugs on patients with mixed dyslipidemia, type 2 diabetes, or the metabolic syndrome.
• Describe the clinical significance of drug interactions that may occur during combination therapy for the management of dyslipidemia.

Faculty

Joseph J. Saseen, Pharm.D., FCCP, BCPS, CLS
Associate Professor, Clinical Pharmacy and Family Medicine
Schools of Pharmacy and Medicine
University of Colorado
Denver, Colorado

Matthew K. Ito, Pharm.D., FCCP, BCPS, CLS
Professor and Chair of Pharmacy Practice
Oregon State University
Oregon Health & Science University
College of Pharmacy
Portland Campus at Oregon Health & Science University

Disclosure Statements

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.

The faculty and planners report the following relationships:

Matthew K. Ito, Pharm.D., FCCP
Dr. Ito declares that he has served as a speaker for Merck.   

Joseph Saseen, Pharm.D., FCCP
Dr. Saseen declares that he has served as a speaker for Daiichi-Sankyo.   

Cathy C. Bowles, R.Ph. and Susan R. Dombrowski, M.S., R.Ph., program planners,  declare that they have no relationships pertinent to this activity.

This activity is supported by an educational grant from Merck/Schering-Plough.

Launch Presentation

Beyond Statins: Persistent Myths & Current Controversies in Managing Dyslipidemia
Presented by Joseph Saseen, Pharm.D., FCCP, BCPS, CLS

HDL Cholesterol as a Therapeutic Target in Patients with Dyslipidemia
Presented by Matthew K. Ito, Pharm.D., FCCP, BCPS, CLS

Challenges in Managing Dyslipidemia in Patients with Mixed Dyslipidemia, Type 2 Diabetes, or the Metabolic Syndrome
Presented by Joseph Saseen, Pharm.D., FCCP, BCPS, CLS

If you would prefer a podcast format of this activity, click here.

Download Post-Test

Click Here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Advantage Testing Center and complete the test online.